Company: OSRH
Filing Date: 2025-01-31
Form Type: 424B3
Source: 0001213900-25-008874
Chunk: 911

Company: OSR Holdings, Inc.
Filing Date: 2025-01-31
Form: 424B3
Chunk 911
---
 |      — |
| rNet Present Value      |     | 69,517 |     |        |     |        |     |        |     |        |     |        |

Annex I-25

rNPV valuation model of Darnatein Co., Ltd. The total enterprise value of Darnatein is USD 104,417,000

| (Unit: USD k)                |     |      Amount |
| Darnatein’s Enterprise Value |     | 104,417,000 |

Estimating Future Cash Flows to Calculate Enterprise Value Darnatein Co., Ltd.
DRT 101 (Osteoarthritis) - 1 / 3 The company’s estimated operating cash flows for the pipeline of osteoarthritis are shown below.

| Currency: USD k      |     |         |     | FY19 |     | FY20 |     | FY21 |     | FY22 |     | FY23 |     |   FY24 |   |     |   FY25 |   |     |    FY26 |   |     |   FY27 |   |     |   FY28 |   |     |   FY29 |   |     |   FY30 |   |     |   FY31 |   |     |   FY32 |   |
| Revenue              |     |         |     |      |     |      |     |      |     |      |     |      |     |      — |   |     |      — |   |     |       — |   |     |      — |   |     |      — |   |     | 10,360 |   |     | 51,800 |   |     | 41,440 |   |     |  3,658 |   |
| Growth%              |     |         |     | n.a  |     | n.a  |     | n.a  |     | n.a  |     | n.a  |     |    n.a |   |     |    n.a |   |     |     n.a |   |     |    n.a |   |     |    n.a |   |     |    n.a |   |     | 400.00 | % |     | -20.00 | % |     | -91.17 | % |
| OPEX                 |     |         |     | —    |     | —    |     | —    |     | —